LABCONNECT APPOINTS WESLEY P. WHEELER AS CHIEF EXECUTIVE OFFICER AND DIRECTOR
With a wealth of expertise, having served as CEO/President of five different companies, Wes is well-equipped to lead LabConnect through its next phase of growth and international expansion. His appointment signals a strategic move as the company continues its upward trajectory in delivering innovative central lab services to a global clientele.
"Wes's deep industry knowledge and experience make him the perfect fit for LabConnect," said Tim Johnson, LabConnect's Chairman and Partner at BroadOak Capital. "We are thrilled to welcome him to the team and confident that he will lead the company to even greater achievements."
Before joining LabConnect, Wes served as President of UPS Healthcare, overseeing a
Wes also serves on several boards, including Chairman of BioTouch and Board Director at Mallinckrodt Pharmaceuticals, Evotec, Envirotainer and Argenta.
"I have worked with LabConnect for many years and am excited to join the company at this pivotal time," said Wheeler. "The company's unique service offerings and business model position it perfectly to meet the evolving needs of the industry. I look forward to working with our team and partners to accelerate LabConnect's growth both domestically and internationally."
For more information about LabConnect, visit www.labconnect.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/labconnect-appoints-wesley-p-wheeler-as-chief-executive-officer-and-director-302261647.html
SOURCE LabConnect
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dr. Rod J. Rohrich and Dr. Angelo Leto Barone Win "Graft Wars" at 71st Annual Plastic Surgery Research Council Meeting
- MissionIRNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) to Acquire CyberCatch for $94.5 Million in All-Cash Transaction
- InventHelp Inventor Develops New Alert Sign for Hospital Rooms (TKA-488)
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share